Tradestie Institutional Equity Comparison Engine

NGEN vs SLSN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLSN Overall Edge

SLSN Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solesence, Inc. Common Stock (SLSN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NGEN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SLSN at 11.4x Forward P/E and 4.5% operating margin (+38.1% YoY). In options structure, NGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLSN sits in CONSOLIDATION (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SLSN
NGEN N/M vs SLSN 11.4x Fwd P/E
Growth & Margin Winner SLSN
Op Margin N/A vs 4.5% ยท YoY N/A vs +38.1%
Momentum & Technical Winner SLSN
1Y -69.5% vs -2.4% ยท 52W Pos 11% vs 58%
Options & Structure Winner SLSN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (N/A IV)
NGEN US Equity
NGEN
Institutional Equity
$1.82
-3.19% 1D
Market Cap N/A
1M Return +14.47%
1Y Return -69.51%
Forward P/E N/M
Unified AI Score
34.7 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0
SLSN NASDAQ
Solesence, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$1.60
+5.26% 1D
Market Cap $107.4M
1M Return +77.78%
1Y Return -2.44%
Forward P/E 11.4x
Unified AI Score
37.1 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NGEN -69.51% SLSN -2.44% Spread: +74.09 pp (SLSN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NGEN TTM Op. Margin: N/A SLSN TTM Op. Margin: 4.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NGEN vs SLSN. Trailing 12-month operating profitability (NGEN N/A vs SLSN 4.5%) and valuation multiples (NGEN N/M vs SLSN 11.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NGEN (1) vs SLSN (9)
Institutional Metric NGEN SLSN Criterion Row Winner
Market Capitalization Scale N/A $107.4M Larger Scale SLSN
Trailing P/E Ratio Valuation N/M 50.7x Lower Multiple SLSN
Forward P/E Ratio Valuation N/M 11.4x Lower Multiple SLSN
Revenue Growth (YoY) Growth N/A +38.1% Higher Growth SLSN
Operating Margin (TTM) Profitability N/A 4.5% Higher Margin SLSN
Net Profit Margin Profitability N/A 3.0% Higher Margin SLSN
Return on Equity (ROE) Capital Efficiency N/A 10.7% Higher ROE SLSN
52-Week Range Position Momentum 11% ($1โ€“$6) 58% ($1โ€“$2) Stronger Trend SLSN
Beta / 30D Volatility Risk Regime 1.25ฮฒ ยท 101% Vol 1.44ฮฒ ยท 238% Vol Lower Realized Risk NGEN
Unified Institutional Score Composite Signal 34.7 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite SLSN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NGEN vs SLSN Buy Guide
NGEN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLSN CONSOLIDATION
130d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SLSN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NGEN nor SLSN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.